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Abstract
Background: Several thousand human genome epidemiology association studies are published
every year investigating the relationship between common genetic variants and diverse phenotypes.
Transparent reporting of study methods and results allows readers to better assess the validity of
study findings. Here, we document reporting practices of human genome epidemiology studies.
Methods: Articles were randomly selected from a continuously updated database of human
genome epidemiology association studies to be representative of genetic epidemiology literature.
The main analysis evaluated 315 articles published in 2001–2003. For a comparative update, we
evaluated 28 more recent articles published in 2006, focusing on issues that were poorly reported
in 2001–2003.
Results: During both time periods, most studies comprised relatively small study populations and
examined one or more genetic variants within a single gene. Articles were inconsistent in reporting
the data needed to assess selection bias and the methods used to minimize misclassification (of the
genotype, outcome, and environmental exposure) or to identify population stratification. Statistical
power, the use of unrelated study participants, and the use of replicate samples were reported
more often in articles published during 2006 when compared with the earlier sample.
Conclusion: We conclude that many items needed to assess error and bias in human genome
epidemiology association studies are not consistently reported. Although some improvements
were seen over time, reporting guidelines and online supplemental material may help enhance the
transparency of this literature.
Published: 20 May 2008
BMC Medical Research Methodology 2008, 8:31 doi:10.1186/1471-2288-8-31
Received: 12 September 2007
Accepted: 20 May 2008
This article is available from: http://www.biomedcentral.com/1471-2288/8/31
© 2008 Yesupriya et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 10
(page number not for citation purposes)
BMC Medical Research Methodology 2008, 8:31 http://www.biomedcentral.com/1471-2288/8/31Background
Human genome epidemiology (HuGE) is a rapidly
emerging scientific field that examines the influence of
genomic variation on human health [1-4]. Although a
large and rapidly increasing number of studies have inves-
tigated the associations between genetic variants and the
risks of common diseases through observational epidemi-
ology, few significant associations have been shown to be
reproducible in multiple studies [5,6]. Transparent report-
ing of the study populations, methods of data collection,
analytic methods, and study inferences may help readers
better identify issues that can affect the reproducibility of
genetic association studies. Here, we conduct a detailed
evaluation of reporting practices for HuGE association
studies.
Methods
In 2001, the Human Genome Epidemiology Network
(HuGENet) established the HuGE Published Literature
database (HuGE Pub Lit), a continually updated, searcha-
ble, online database of population-based, genetic epide-
miology articles [7]. Relevant studies are identified weekly
from NCBI PubMed [8] by a genetic epidemiologist who
records the study design, genes and diseases of interest,
and interacting environmental factors [7]. As of May 21,
2007, this database included a total of 27,386 articles that
examined genotype-phenotype associations (both quali-
tative and quantitative traits) published in 2,773 journals.
Further details regarding the contents of this database
have been previously described [7]. This information
along with the title, contributing authors, abstract, jour-
nal, date of publication, and the unique PubMed Identi-
fier (PMID) are deposited in the HuGE Pub Lit database
[7]. To select articles for this analysis, we queried the
HuGE Pub Lit database for population-based studies that
used observational study designs (i.e., case-control,
cohort, and cross-sectional studies) to investigate gene-
disease associations, interactions between genetic variants
(interlocus or gene-gene interactions), or gene-environ-
ment interactions. Family-based linkage studies were not
collected systematically in HuGE Pub Lit and, therefore,
were not included in this study. In addition, we restricted
our analysis to full text articles because studies presented
only as concise summaries (e.g., as letters or abstracts)
could have increased the heterogeneity of our sample.
Our evaluation was designed in 2004 and data collection
and analyses were conducted in 2004–2007. For the main
analysis, we drew a five percent simple random sample
(SRS) of articles that were returned by the query described
above, published from 2001 to 2003, and curated in
HuGE Pub Lit before May 30th, 2004 (n = 8,115) to yield
a dataset of 406 articles. To provide an updated descrip-
tion of reporting practices and to assess improvements in
reporting, we randomly selected (SRS) 40 articles that
were published during 2006 from articles that were
returned by our database query, added to PubMed in
2006, and curated in HuGE Pub Lit before May 18, 2007
(n = 5,353). After each article was read, 91 from 2001–
2003 and 12 from 2006 were excluded from the analysis
for the following reasons: not written in English (2001–
2003: n = 28, 2006: n = 6), population screening studies
(2001–2003: n = 23, 2006: n = 0), clinical trials or phar-
macogenomic studies (2001–2003: n = 16, 2006: n = 3),
not full-length articles (i.e., letter or abstract) (2001–
2003: n = 11, 2006: n = 0), failed to fulfill the inclusion
criteria for HuGE Pub Lit [7] on closer scrutiny (2001–
2003: n = 6, 2006: n = 1), family studies (2001–2003: n =
3, 2006: n = 2), studies of genetic tests (2001–2003: n = 2,
2006: n = 0), or meta-analyses (2001–2003: n = 2, 2006:
n = 0).
Data were abstracted from each original publication in
duplicate by two independent data extractors. All discrep-
ancies between the independent extractors were discussed
and a consensus was reached.
For the 2001–2003 articles, a standardized abstraction
form was developed and piloted for 10 articles; the form
was revised according to the results of this pilot study to
ensure that the definitions for the collected items were
clear and unambiguous. Items on this final form were
designed to collect information on the reporting of study
design, genotyping method, population stratification,
analytical methods (including the analysis of multiple
genetic variants and gene-environment interactions), and
study inferences. In addition, the final form accommo-
dated different observational study designs, multiple
groups of study participants, and the consideration of
more than one postulated genetic risk factor as well as
additional environmental factors. Articles were coded as
potentially misclassifying the disease or environmental
exposure status of study participants when the article did
not explicitly state that these factors were directly meas-
ured for all participants in the study population. When
multiple groups of study participants were reported in a
study, we recorded the sample size of the largest group for
cohort and cross-sectional studies and the largest case and
control groups for case-control studies. Items were col-
lected separately for case and control groups for case-con-
trol studies and for all study participants regardless of
disease status for cohort and cross-sectional studies. For
the purpose of this analysis, data collected for case and
control groups were combined so that statistics could be
calculated for all study participants. Information (e.g.,
mean or median age and sex distribution) was considered
as given for all study participants only if it was provided
for all case and control groups. Additionally, for case-con-
trol studies, we recorded whether cases and controls were
described as drawn from the same population accordingPage 2 of 10
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region, 2) clinical population, 3) general population (i.e.,
ethnic group), or whether information on the choice of
suitable controls was missing or incomplete.
Fourteen items were assessed in the HuGE articles pub-
lished in 2006. These included the number of study par-
ticipants, genes, polymorphisms, and environmental
factors assessed in gene-environment interactions. In
addition, we selected ten items that were applicable to all
study designs and that had been reported in fewer than
50% of the articles published in 2001–2003.
The data analysis was conducted using SAS 9.13 (SAS
Institute, Cary, NC). Counts and percents were calculated
for the items abstracted from the articles. Comparisons of
articles published in 2006 vs. those published in 2001–
2003 used the Mann-Whitney U test for continuous vari-
ables and Fisher's exact test for binary variables.
Results
HuGE articles published from 2001 to 2003
The 315 articles selected for analysis were published in
194 journals and reported on the findings of 227 case-
control, 32 cohort, and 56 cross-sectional studies. In addi-
tion to population-based studies, three articles also
described family-based analyses. Data pertaining exclu-
sively to these family-based analyses were not included in
this report. As shown in Table 1, most articles (75.9 per-
cent) reported sample sizes of fewer than 500 study partic-
ipants; 9.2 percent reported sample sizes greater than or
equal to 1,000 (median = 265, interquartile range (IQR)
142–471). Statistical power was reported in 12.7 percent
of articles. Multiple study populations (e.g., more than
one case or control group) were reported in 25.4 percent
of the articles. Most of the studies provided at least some
information about the origin (87.9 percent) and the
enrollment criteria (97.5 percent) of the study partici-
pants. The sex distribution was provided in three-quarters
of the articles, whereas the median or mean age of the
study participants and a measure of the variation around
this value (e.g., IQR or standard deviation) were reported
for 65.4 percent and 54.6 percent, respectively. One in six
articles explicitly stated that the study participants were
unrelated. We estimated that 11.8 percent of studies could
have misclassified the outcome of interest.
Seven percent of studies reported that the genotyping
results were validated with the use of replicate samples,
and an additional 9.8 percent reported that a different
method of validation was used (Table 2). A blind evalua-
tion of the genetic test to the outcome (11.1 percent) or of
the outcome to the genetic test (3.8 percent) was rarely
reported. Few articles reported that any potential partici-
pants had been excluded (11.8 percent) or commented on
the number of samples that could not be genotyped (15.6
percent).
As shown in Table 3, almost 60 percent of the articles indi-
cated that all study participants were drawn from the same
ethnic population, whereas 9.5 percent reported that the
study population included more than one ethnic group.
Most of these articles (76.7 percent) either stratified by or
controlled for ethnicity; however, a few (23.3 percent)
pooled ethnic groups together or did not provide clear
information on how data from different ethnic groups
were analyzed. The use of unlinked genetic markers to
assess population stratification was extremely rare (0.6
percent). Among case-control studies (n = 227), two-
Table 1: Reporting characteristics of the study design for 315 
randomly selected HuGE articles (2001–2003)
Reporting characteristic Count Percent
Number of study participants
< 100 49 15.6
100–499 190 60.3
500–999 47 14.9
>= 1000 29 9.2
Reported the available power of the study
No 275 87.3
Yes 40 12.7
Reported that multiple study populations or case 
or control groups were used
No 235 74.6
Yes 80 25.4
Provided any information on the origin of the 
study participants
No 38 12.1
Yes 277 87.9
Provided any information on the enrollment 
criteria for the study participants
No 8 2.5
Yes 307 97.5
Sex distribution reported for all study 
participants
No 84 26.7
Yes 231 73.3
Mean or median age reported for all study 
participants
No 109 34.6
Yes 206 65.4
Standard deviation or interquartile range 
reported for all study participants
No 143 45.4
Yes 172 54.6
Explicitly stated the use of unrelated study 
participants
No 259 82.2
Yes 56 17.8
Potential for outcome misclassification
No 272 86.3
Unclear 6 1.9
Yes 37 11.8Page 3 of 10
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from the same geographic area; one in five indicated that
cases and controls were drawn from the same clinical pop-
ulation, and one-quarter indicated that cases and controls
were drawn from the same general population. More than
one-third of these articles were unclear about the source
populations or reported no information at all on this
aspect.
Approximately one-half of the articles stated that they
examined whether the study populations were in Hardy-
Weinberg equilibrium; of these, 6.6 percent reported that
the genotype frequencies deviated from those expected
under Hardy-Weinberg equilibrium (Table 4). Summary
data (e.g., genotype/allele frequencies presented in a tab-
ular format) were reported on all genetic variants of inter-
est for the outcomes in 87 percent of articles. Analysis
using alleles (54.6 percent) was less common than analy-
sis using genotypes (85.7 percent). When genotypes were
analyzed, a considerable proportion of articles reported
on specific genetic comparisons based on dominant or
recessive models (20.7 percent); among these studies,
41.1 percent provided a justification for using the selected
model. One in ten articles reported corrections for multi-
ple comparisons; most (70.0 percent) used a Bonferroni
correction as the method of adjustment. One article
reported using both Tukey's and Scheffe's tests to control
for multiple comparisons [9].
Overall, less than 40 percent of the articles discussed the
public health, medical, or clinical implications of their
findings. Less than one in six articles claimed to be the first
to analyze a particular association. For the articles that did
not make this claim, 8.6 percent clearly made reference to
the first study on the issue. Six percent of articles clearly
referenced a systematic review, and 1.9 percent referenced
a non-systematic review.
Nearly two-thirds of the articles (N = 201) investigated
multiple genetic variants, often in more than one gene
(Table 5). These studies varied in their reporting of linkage
disequilibrium (22.9 percent), haplotype analysis (21.4
percent), and gene-gene interactions (24.4 percent).
When articles reported on interlocus or gene-gene interac-
tions, slightly over half estimated the relative risk of the
phenotypic outcome as an odds ratio; only 4.1 percent
Table 3: Reporting characteristics of population stratification for 
315 randomly selected HuGE articles (2001–2003)
Reporting characteristic Count Percent
Explicitly stated that all study participants were 
drawn from the same ethnic population
Unclear 130 41.3
Stated 185 58.7
Analysis conducted by using different ethnic 
groups
No 285 90.5
Yes 30 9.5
If different ethnic groups were included, how 
was ethnicity treated in the analysis (n = 30)
Stratified by or adjusted for ethnic groups 23 76.7
Pooled ethnic groups together 2 6.7
Unclear 5 16.6
Reported that unlinked genetic markers were 
used to identify population stratification
No 313 99.4
Yes 2 0.6
Reported that cases and controls were drawn 
from the same population in regards to 
geography (n = 227)
No 79 34.8
Yes 148 65.2
Reported that cases and controls were drawn 
from the same population in regards to the 
clinical population (n = 227)
No 180 79.3
Yes 47 20.7
Reported that cases and controls were drawn 
from the same population in regards to the 
general population (n = 227)
No 167 73.6
Yes 60 26.4
Reported unclear or no information regarding 
the population from which cases and controls 
were drawn (n = 227)
No 142 62.6
Yes 85 37.4
Table 2: Reporting characteristics of the genotyping method for 
315 randomly selected HuGE articles (2001–2003)
Reporting characteristic Count Percent
Reported that the genotyping results were 
validated by using duplicate samples
No 293 93.0
Yes 22 7.0
Reported that the genotyping results were 
validated by using a different method
No 284 90.2
Yes 31 9.8
Reported that the evaluation of the genetic test 
was blind to the outcomes or phenotypes
Blind 35 11.1
Unclear 280 88.9
Reported that the evaluation of the outcomes 
or phenotypes was blind to the genetic test
Blind 12 3.8
Unclear 303 96.2
Reported that individuals were excluded from 
the original group(s) of study participants
No 278 88.2
Yes 37 11.8
Reported that several samples could not be 
genotyped
No 266 84.4
Yes 49 15.6Page 4 of 10
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attributable fraction. The remainder did not present a
measure of risk. One-half of the studies that reported on
interlocus or gene-gene interactions reported that at least
one of these interactions was statistically significant.
Gene-environment interactions were discussed in 15.2
percent (n = 48) of the articles (Table 6). Among these
articles, 70.8 percent examined one environmental factor,
20.8 percent examined two, and 8.4 percent examined
Table 5: Reporting characteristics of the analysis of multiple 
genetic variants for 315 randomly selected HuGE articles (2001–
2003)
Reporting characteristic Count Percent
Number of genes analyzed
1 188 59.7
2 71 22.5
>= 3 56 17.8
Number of genetic variants analyzed
1 114 36.2
2 85 27.0
3 56 17.8
4 21 6.6
>= 5 39 12.4
Reported on linkage disequilibrium (among those 
studying 2 or more polymorphisms) (n = 201)
No 155 77.1
Yes 46 22.9
Reported on an analysis using haplotypes (among 
those studying 2 or more polymorphisms) (n = 
201)
No 158 78.6
Yes 43 21.4
Reported on a interlocus or gene-gene 
interaction (among those studying 2 or more 
polymorphisms) (n = 201)
No 152 75.6
Yes 49 24.4
If interlocus or gene-gene interactions were 
assessed, was risk quantified as an odds ratio or 
risk ratio (n = 49)
No 22 44.9
Yes 27 55.1
If interlocus or gene-gene interactions were 
assessed, was risk quantified as an absolute 
difference (n = 49)
No 47 95.9
Yes 2 4.1
If interlocus or gene-gene interactions were 
assessed, was risk quantified as an attributable 
fraction (n = 49)
No 49 100.0
Yes 0 0.0
If interlocus or gene-gene interactions were 
assessed, claim was made of a statistically 
significant interaction (n = 49)
No 24 49.0
Yes 25 51.0
Table 4: Reporting characteristics of the analytic methodology 
and study inferences for 315 randomly selected HuGE articles 
(2001–2003)
Reporting characteristic Count Percent
Reported that all genetic variants were examined 
for Hardy-Weinberg equilibrium
No 164 52.1
Yes 151 47.9
If Hardy-Weinberg equilibrium was reported, did 
any polymorphism reportedly fail Hardy-
Weinberg equilibrium (n = 151)
No 141 93.4
Yes 10 6.6
Summary data reported on all genetic variants of 
interest for all outcomes
No 41 13.0
Yes 274 87.0
Reported that analyses were conducted by using 
allele-based genetic comparisons
No 143 45.4
Yes 172 54.6
Reported that analyses were conducted by using 
genotype-based genetic comparisons
No 45 14.3
Yes 270 85.7
If the analyses were conducted by using 
genotypes, were selected comparisons or all 
possible comparisons assessed (n = 270)
All possible 214 79.3
Selected 56 20.7
Justifications given for the selection of specific 
genetic comparisons (n = 56)
No 33 58.9
Yes 23 41.1
Adjustment for multiple comparisons used
No 276 87.6
Yes 39 12.4
If an adjustment for multiple comparisons was 
used, type of adjustment was (n = 40, one article 
used two methods)
Bonferroni 28 70.0
Fischer's post hoc 1 2.5
Monte Carlo simulations 1 2.5
Scheffe's test 2 5.0
Tukey's test 3 7.5
Unknown 5 12.5
Authors discussed the public health, medical, or 
clinical implications of their findings
No 193 61.3
Yes (any mention) 122 38.7
Authors stated that this is the first study on the 
specific issue
No 266 84.4
Yes 49 15.6
Clear reference made to the first study on the 
specific issue (n = 266)
No 243 91.4
Yes 23 8.6
Clear reference made to a systematic review
No 297 94.3
Yes 18 5.7
Clear reference made to a non-systematic review
No 309 98.1
Yes 6 1.9Page 5 of 10
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sify the environmental factor was present in as many as
three-fourths of the articles. Very few studies (6.2 percent)
presented a description of the possible sources of error in
the measurement of the environmental factor or reported
the use of dose-dependent models. None of the articles
indicated whether the assessment of the environmental
factor was blinded to genotype or whether laboratory staff
performing the genetic tests was blind to the environmen-
tal factor. Risk was quantified as a risk or odds ratio in
slightly more than one-half of these studies; however,
none reported absolute differences or attributable frac-
tions. A statistically significant gene-environment interac-
tion was reported in 29.2 percent of the papers.
Comparison of reporting practices in 2001–2003 with 2006
The number of study participants, genes and polymor-
phisms analyzed, and environmental factors examined in
gene-environment interactions were similar for the two
time periods (Table 7). Articles in the 2006 sample tended
to use sample sizes of less than 500 (75.0 percent) and
report on a single gene (75.0 percent), multiple genetic
variants (64.3 percent), and no gene-environment interac-
tions (92.9 percent).
Three of the ten items that were reported in fewer than 50
percent of the articles from 2001–2003 were reported sig-
nificantly more often in the 2006 articles (Table 7). Stud-
ies published in 2006 were more likely to report the
available power of the study (2001–2003: 12.7 percent;
2006: 28.6 percent; p = .03), the use of unrelated study
participants (2001–2003: 17.8 percent; 2006: 35.7 per-
cent; p = .03), and the validation of genotypic results
using duplicate samples (2001–2003: 7.0 percent; 2006:
21.4 percent; p = .02). Nevertheless, every item except for
Hardy-Weinberg equilibrium was reported in fewer than
half of all articles in the 2006 sample.
Discussion
Many published claims of gene-disease association have
not been replicated when studied in independent samples
[5,6]. Suspected causes of this inconsistency include the
assessment of statistical significance without accounting
for the low prior probability of association, low statistical
power, improper selection of participants, measurement
error, confounding, and the selective reporting of results
in the published literature [1,2,5,6,10-15]. Previous anal-
yses have found that many published articles in genetic
epidemiology do not provide sufficient information to
evaluate these causes [16-18]. However, the results of
these analyses were limited to a specific phenotypic out-
come (e.g., sepsis) [16,17] or are outdated [18]. Our anal-
ysis provides an updated review of reporting on these key
elements in two representative samples of HuGE articles.
Representative of the literature in this field, most of the
studies in our samples were small: only about 10 percent
of the studies reported sample sizes that exceeded 1,000.
Several meta-analyses have found significant differences
between the results of small and large genetic association
studies [6,19]. Growing evidence suggests that individual
genetic variants impart only a modest effect on the risk of
developing complex, multifactorial diseases [20-22].
Table 6: Reporting characteristics for the analysis of interacting 
environmental factors for randomly selected HuGE articles 
(2001–2003)
Reporting characteristic Count* Percent
Number of environmental factors assessed in 
gene-environment interactions
1 34 70.8
2 10 20.8
>= 3 4 8.4
Potential for misclassification of the 
environmental factors
No 7 14.6
Unclear 4 8.3
Yes 37 77.1
Provided a description of possible error in the 
measurement of the environmental factor
No 45 93.8
Yes 3 6.2
Use of dose-depending models
No 45 93.8
Yes 3 6.2
Reported that the evaluation of the genetic 
test was blind to the environmental factor
Blind 0 0.0
Unclear 48 100.0
Reported that the evaluation of the 
environmental factor was blind to the genetic 
test
Blind 0 0.0
Unclear 48 100.0
If gene-environmental interactions were 
assessed, was risk quantified as an odds ratio 
or risk ratio
No 22 45.8
Yes 26 54.2
If gene-environmental interactions were 
assessed, was risk quantified as an absolute 
difference
No 48 100.0
Yes 0 0.0
If gene-environmental interactions were 
assessed, was risk quantified as an attributable 
fraction
No 48 100.0
Yes 0 0.0
Claim of a statistically significant gene-
environmental interaction
No 34 70.8
Yes 14 29.2
* limited to the 48 studies that addressed at least 1 environmental 
factorPage 6 of 10
(page number not for citation purposes)
BMC Medical Research Methodology 2008, 8:31 http://www.biomedcentral.com/1471-2288/8/31Thus, enrolling many thousands or even tens of thou-
sands of individuals may be required to achieve the neces-
sary power to identify and validate true genetic
associations [13,20,23,24].
Our ability to assess the potential for selection biases was
severely limited in many of the studies we examined.
Although most studies provided some qualitative descrip-
tions of the study participants (such as origin and enroll-
Table 7: Comparison of the reporting characteristics of HuGE articles from two time periods (2001–2003 vs. 2006)
Published from 2001–2003 Published in 2006
Reporting characteristic Count Percent Count Percent P-Valuea
Basic descriptive items
Number of study participants
< 100 49 15.6 5 17.9 0.90
100–499 190 60.3 16 57.1
500–999 47 14.9 4 14.3
>= 1000 29 9.2 3 10.7
Number of genes analyzed
1 188 59.7 21 75.0 0.12
2 71 22.5 4 14.3
>= 3 56 17.8 3 10.7
Number of genetic variants analyzed
1 114 36.2 10 35.7 0.29
2 85 27.0 4 14.3
3 56 17.8 6 21.4
4 21 6.6 1 3.6
>= 5 39 12.4 7 25.0
Number of environmental factors examined in gene-environment interactions
1 34 70.8 1 50.0 0.26
2 10 20.8 1 50.0
>= 3 4 8.4 0 0.0
Items applicable to all articles that were addressed in less than 50% of the 2001–2003 HuGE articles
Reported the available power of the study
No 275 87.3 20 71.4 0.03
Yes 40 12.7 8 28.6
Explicitly stated the use of unrelated study participants
No 259 82.2 18 64.3 0.03
Yes 56 17.8 10 35.7
Reported that genotyping results were validated using duplicate samples
No 293 93.0 22 78.6 0.02
Yes 22 7.0 6 21.4
Reported that genotyping results were validated using a different method
No 284 90.2 24 85.7 0.32
Yes 31 9.8 4 14.3
Reported that the evaluation of the genetic test was blind to outcomes or phenotypes
Blind 35 11.1 3 10.7 0.62
Unclear 280 88.9 25 89.3
Reported that the evaluation of the outcomes or phenotypes was blind to the genetic test
Blind 12 3.8 2 7.1 0.32
Unclear 303 96.2 26 92.9
Reported that individuals were excluded from the original group(s) of study participants
No 278 88.2 26 92.9 0.86
Yes 37 11.8 2 7.1
Reported that several samples could not be genotyped
No 266 84.4 23 82.1 0.46
Yes 49 15.6 5 17.9
Reported that unlinked genetic markers were used to identify population stratification
No 313 99.4 28 100.0 1.00
Yes 2 0.6 0 0.0
Reported that all genetic variants were examined for Hardy-Weinberg equilibrium
No 164 52.1 12 42.9 0.23
Yes 151 47.9 16 57.1
a P-values were determined from two-sided Mann-Whitney U tests for the basic descriptive items and one sided Fisher's Exact Tests for the items that were reported in less 
than 50% of the 2001–2003 articles.Page 7 of 10
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descriptors, such as age and sex. Potentially important
details, such as the number of exclusions or the number of
samples that could not be genotyped, were often omitted.
Misclassification can severely limit study power and bias
the results [14,23,25-27]. We determined about a tenth of
studies may have misclassified their phenotypic outcomes
and three-fourths of studies may have misclassified their
environmental factors. A small proportion of studies
reported measures such as genotyping replicate samples
and blinding the research staff [27,28] to help ensure that
the genetic data were not misclassified. Although the prac-
tice of detecting genotyping errors through tests of Hardy-
Weinberg Equilibrium is still being debated [27,29-31],
approximately half of studies reported HWE test results.
Population stratification may occur when study partici-
pants are selected from subpopulations with a different
prevalence of the phenotypes and genotypes
[21,30,32,33]. Although the extent to which population
stratification contributes to spurious findings remains
debatable [34-36], most of the articles in our sample pro-
vided descriptions for the ethnic origin of the study partic-
ipants, and almost all case-control studies indicated that
the cases and controls were drawn from the same popula-
tion. A few studies reported the use of unlinked markers
to provide evidence that population stratification was not
an issue in the analysis. Genome-wide association studies
provide considerable genetic data to examine and correct
for population stratification (e.g. by principal component
analysis) [37-39].
As a result of the selective reporting of significant results
from multiple analyses and publication bias, the extent of
type I error in the published literature may be great
[11,14,21,23,26,28,30,40,41]. Although most studies
reported results for only a few polymorphisms and envi-
ronmental factors, it is difficult to determine the number
actually tested; only a minority of articles reported using
corrections for multiple comparisons, even for the
reported associations. Reporting justifications for specific
genetic comparisons could suggest that studies were
founded on an a priori hypothesis and were not the result
of selective reporting. However, less than one-half of the
studies that assessed dominant or recessive genetic mod-
els provided justifications for the use of these specific
comparisons and not others. Among articles that
described gene-gene or gene-environment interactions, a
substantial proportion reported statistically significant
results. However, many of these may be spurious, given
the limited power of most studies to identify true associa-
tions, let alone interaction effects [20,32]. The high fre-
quency of "positive" results in our study sample could
reflect a combination of multiple testing, selective report-
ing, and publication bias [14].
The use of common reporting standards could increase
the transparency of research methodology, thus helping
to identify selective reporting and sources of bias and con-
founding while allowing for a more complete synthesis of
data across consortia or in meta-analyses [1,10,42]. The
results of our study were presented at a HuGENet spon-
sored workshop, Strengthening the Reporting of Genetic
Associations (STREGA) [43]. The workshop concluded
with an agreement to develop an extension of the STROBE
(STrengthening the Reporting of OBservational studies in
Epidemiology) statement [44] to address some of the spe-
cific challenges (e.g., generation of genetic data, popula-
tion stratification, haplotype inference, HWE, and
multiple testing) posed by reporting results of genetic epi-
demiology studies. STREGA is currently finalized for pub-
lication, as of writing this article.
By publishing supplementary information online, jour-
nals increasingly provide authors the opportunity to
present their study methods and results in greater detail
than is permitted in print [45,46]. Recently, an increase in
such supplements–often used to report additional meth-
ods, tables, and figures–was documented for a number of
high impact journals [45]. However, authors and journals
need to ensure that this information remains available to
readers and is not lost in broken links [46].
Conclusion
In summary, our results provide evidence that many
details needed to assess the validity of study findings are
not consistently reported in human genome epidemiol-
ogy studies, though some improvement has been seen
recently. The use of standard reporting guidelines and
online supplements could help readers to better judge the
scientific evidence. As large-scale genotyping platforms
are rapidly introduced in human genome epidemiology,
the importance of transparent reporting of the back-
ground, epidemiological methods, and population char-
acteristics cannot be understated given the challenge of
assessing, interpreting, and discussing ever-greater
amounts of data.
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